CFTR and cystic fibrosis: The resulting highly branched PAE NP, combined with CFTR plasmid depleted of CpG, demonstrated enhanced gene expression of CFTR and biocompatibility in lung epithelial cells, successfully restoring functional CFTR protein production and showing promise as an efficient and safe treatment for CF patients (Fig. 8C) [347].